Skip to main navigation Skip to search Skip to main content

The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells

  • Noortje Van Gils
  • , Tania Martiañez Canales
  • , Eline Vermue
  • , Arjo Rutten
  • , Fedor Denkers
  • , Tiem Van Der Deure
  • , Gert J. Ossenkoppele
  • , Francis Giles
  • , Linda Smit
  • VU University Medical Center
  • Epigene Therapeutics Consortium

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science